Hualan Biological Engineering

Update in progress

002007.SZ (Shenzhen)

Hualan Biological Engineering Inc. and its subsidiaries develop, manufacture, and market biological products in China and overseas. The company offers blood products such as human serum albumin, coagulation factors, fibrinogen, and fibrin sealant; intravenous immunoglobulin and vaccines including influenza, meningococcal, hepatitis B, rabies, and tetanus. It also develops monoclonal antibodies and biosimilars in various trial stages, including rituximab, adalimumab, denosumab, trastuzumab, and Exendin-4-FC. Founded 1992, Xinxiang, China.